Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The SET nuclear oncogene pseudogene (ENSG00000240404) is a non-functional DNA segment in the human genome that bears high sequence similarity to the protein-coding SET nuclear oncogene but lacks coding capacity due to disruptive mutations or missing regulatory elements. Pseudogenes like this are generally not transcribed or translated into protein and are not considered receptors, enzymes, or other classical drug targets. However, emerging evidence shows that some pseudogenes can modulate expression of related genes through non-coding RNA activities, such as acting as competing endogenous RNAs (ceRNAs), miRNA sponges, or antisense transcripts; when such functions exist, they are often implicated in cancer biology but are rarely direct therapeutic targets. No drugs, biomarkers, or specific therapeutic mechanisms are recognized for the SET nuclear oncogene pseudogene. The presence of “pseudogene” in the name and its Ensembl annotation as a pseudogene indicate that this entry should not be treated as a conventional molecular target. If you meant to refer to the functional SET nuclear oncogene (Ensembl gene: ENSG00000119335), information would differ substantially. This entry encodes a pseudogene, not a protein or receptor, and should not generally be included in structured therapeutic target databases. If a functional target is required, consult the canonical SET gene/protein rather than this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SET nuclear oncogene pseudogene.